Editorial draft — not for publication yet. Methylphenidate content needs review by a qualified UK healthcare professional before publication. For advice about your own prescription, contact your prescriber or pharmacist.

Quick answer

Follow the patient leaflet for the exact methylphenidate product you take. Advice can depend on formulation and how close it is to the next scheduled dose.

Brand-specific product guides for Methylphenidate: Ritalin, Alaradate, Methyphen. These are separate from the generic guide.

If you miss a dose

Do not double a dose to make up for one you missed. If the label is unclear or you are unsure what to do, ask a pharmacist or prescriber.

If you may have taken too much

Taking more methylphenidate than prescribed can be dangerous. Seek urgent medical advice through NHS 111 or your local urgent-care service and have the medicine pack available so professionals can identify the product and strength.

Do not wait for symptoms to become severe if you are worried about an overdose, and do not drive yourself for medical help.

Call 999 for severe symptoms

Call 999 for chest pain, seizure, collapse, severe agitation, difficulty breathing, loss of consciousness or another life-threatening symptom. Tell responders what was taken, how much is known and when.

Keep the packaging and any remaining tablets for clinicians. Do not induce vomiting or try to manage a significant overdose at home.

Need help in the UK? Call 999 for a life-threatening emergency. For urgent medical advice that is not an emergency, contact NHS 111. Ask a pharmacist or prescriber about your specific medicine.

Frequently asked questions

Should I take two methylphenidate tablets if I missed one?

No. Do not double a dose. Follow the leaflet for your exact product or ask a pharmacist.

What should I do if I took too much methylphenidate?

Contact NHS 111 or urgent medical services for advice, even if symptoms are not severe. Keep the packaging available.

When is a methylphenidate overdose an emergency?

Call 999 for chest pain, seizure, collapse, severe agitation, difficulty breathing, unconsciousness or other life-threatening symptoms.

Sources and further reading

This page is based on the following UK sources. Check the leaflet supplied with your own product, as advice can differ between formulations.

Editorial status: Editorial draft — clinical review required before publication. Sources checked on 2 October 2026.

Related information

Read the Methylphenidate overview or continue to another topic: